Emerging Biotech determines business impact of potential application outages.
Following a Cybersecurity Risk Assessment, an emerging biotech company discovered several applications were lacking contingency plans for possible outages. Further, the company was unclear about how the unavailability of these applications would impact business continuity and overall performance.
To develop the appropriate contingency and recovery plans, the biotech partnered with Triverus to conduct a business continuity assessment. Triverus’ Life Sciences team was charged with identifying key business processes and the associated applications on continued business performance and determining the impact of unavailability. Activities included:
Utilizing a proven assessment methodology to evaluate the current environment and its capabilities via:
Utilizing the findings, Triverus provided a set of recommendations prioritized by risk and level of importance to the business.
The comprehensive set of actionable recommendations provides the client with:
Additionally, the client has a repeatable approach for continued assessment and improvement of existing or new applications, including:
Need an Assessment and Roadmap for your next initiative?
Connect with our team